ABSTRACT
Background Recent evidence suggests that adolescents exhibiting conduct problems (CP) may have disrupted brain connectivity at rest. However, these studies are generally characterized by small sample sizes and differ in terms of neuroimaging methodologies and chosen psychometric scales to assess CP. In parallel, evidence from genetic and structural imaging studies suggests that aggregating measures may increase generalizability and reproducibility in results. Our primary aim was to identify deficits in functional brain connectivity that were replicable across two distinct measures of CP.
Methods In a large sample of adolescents (n=1416), we assessed the relationship between resting-state functional connectome (including the amygdala bilaterally) and two distinct measures of conduct problems. Positive and negative brain connectivity measures were derived from the intersection of both scales. The utility of these aggregated scores was assessed in comparison with variants of psychopathy and clinical diagnoses.
Results Psychometrics scales assessing CP were significantly related to 231 & 269 disrupted functional connectivity. Only 21 brain connectivity were shared between the two scales (10 positively and 11 negatively associated with CP. These brain connectivity scores differed between adolescents with variants of psychopathy and healthy controls and were specifically associated with disruptive disorders, but not other pediatric psychiatric disorders.
Conclusion The current study provides the evidence that different measures of CP may yield distinct results. Nonetheless, it also highlights that functional brain connectivity that intersected between the two scales may be robust and reliable neurobiological markers of severity of CP. Finally, brain connectivity scores may be generalizable to variants of psychopathy and specific to disruptive disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Healthy Brain Network
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors